title: Induction of apoptosis by epigallocatechin-3-gallate in human lymphoblastoid B cells.
abstract: (-)-Epigallocatechin-3-gallate (EGCG), a major constituent of green tea polyphenols, has been shown to suppress cancer cell proliferation and induce apoptosis. In this study we investigated its efficacy and the mechanism underlying its effect using human B lymphoblastoid cell line Ramos, and effect of co-treatment with EGCG and a chemotherapeutic agent on apoptotic cell death. EGCG induced dose- and time-dependent apoptotic cell death accompanied by loss of mitochondrial transmembrane potential, release of cytochrome c into the cytosol, and cleavage of pro-caspase-9 to its active form. EGCG also enhanced production of intracellular reactive oxygen species (ROS). Pretreatment with diphenylene iodonium chloride, an inhibitor of NAD(P)H oxidase and an antioxidant, partially suppressed both EGCG-induced apoptosis and production of ROS, implying that oxidative stress is involved in the apoptotic response. Furthermore, we showed that combined-treatment with EGCG and a chemotherapeutic agent, etoposide, synergistically induced apoptosis in Ramos cells.
authors.affiliation: Department of Nutrition Management, Faculty of Health Science, Hyogo University, Kakogawa, Hyogo 675-0101, Japan. cnoda@hyogo-dai.ac.jp
authors.forename: Chiseko
authors.initials: C
authors.lastname: Noda
authors.forename: Jinsong
authors.initials: J
authors.lastname: He
authors.forename: Tomoko
authors.initials: T
authors.lastname: Takano
authors.forename: Chisato
authors.initials: C
authors.lastname: Tanaka
authors.forename: Toshinori
authors.initials: T
authors.lastname: Kondo
authors.forename: Kaoru
authors.initials: K
authors.lastname: Tohyama
authors.forename: Hirohei
authors.initials: H
authors.lastname: Yamamura
authors.forename: Yumi
authors.initials: Y
authors.lastname: Tohyama
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage; D017209:Apoptosis / Q000187:drug effects*; D051017:Apoptosis Regulatory Proteins / Q000378:metabolism*; D002392:Catechin / Q000008:administration & dosage / Q000031:analogs & derivatives*; D002460:Cell Line; D002470:Cell Survival / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D006801:Humans; D016393:Lymphoma, B-Cell / Q000378:metabolism* / Q000473:pathology*; D017382:Reactive Oxygen Species / Q000378:metabolism*; D015398:Signal Transduction / Q000187:drug effects